본문 바로가기 주메뉴 바로가기
About MEDIFIC

History

History
MEDIFIC
2020
  • 01. Jul.
    Joint research contract with DGMIF for the development of ‘First-in-Class drug’ (Structural Biology) / MFC-3
  • 29. Apr.
    Selected as military service designated company
  • 01. Mar.
    Joint research contract with DGMIF for the development of ‘First-in-Class drug’ (Molecular design) / MFC-3

2019
  • 01. Sep.
    Joint research contract with DGMIF for the development of ‘First-in-Class drug’ (Structural Biology) / MFC-1
  • 01. Sep.
    Joint research contract with DGMIF for the development of ‘First-in-Class drug’ (Optimization) / MFC-1
  • 15. Aug.
    Joint research contract for the development of cancer stem cell target therapy (CGRL in Korea University)
  • 01. Jul.
    Selection for One-Stop support project of DGMIF (1.1 million dollars) / MFC-1
  • 21. Jun.
    Seed funding from institutional investment (5 million dollars)
  • 11. Feb.
    Certification of venture company (#20190100921)
2018
  • 12. Jul.
    Certification of Research Institute in MEDIFIC (#2018113591)
  • 07. Feb.
    MEDIFIC Established